New Mexico Injury Lawyer Blog
The officials voting today were presented with multiple choice questions. Question three had a choice of
A. The data provides sufficient evidence to raise significant safety concerns in diabetes type 2 patients taking Rosiglitazone (Avandia).
B. The data does not provide sufficient evidence to raise significant safety concerns in diabetes type 2 patients taking Avandia.